Navigation Links
VIVUS Provides Regulatory Update on QNEXA
Date:9/15/2011

pected to include four distinct medical and pharmacy claim databases.  

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial QNEXA NDA on October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate" and "intend," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the timing and substance of our response to the FDA's requests from the End of Review meeting; our response to, and continued dialogue with, the FDA relating to matters raised in the FDA's CRL; the timing and results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy or FORTRESS; the FDA's interpretation of and agreement with the information VIVUS submitted and may submit relating to teratogenicity and cardiovascular safety; the FDA's interpretation of the data from our SEQUEL study, or OB-305; the FDA's requests, if any, to cond
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
2. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
3. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
4. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
5. VIVUS to Present at Three Upcoming Investor Conferences in March
6. VIVUS Provides Regulatory Update on QNEXA NDA
7. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
8. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
9. VIVUS to Present at Two Upcoming Investor Conferences
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... LEWIS CENTER, Ohio , May 22, 2013 ... of Opioid Defense Manager™ (ODM).  Launched in November ... Medical,s revolutionary managed care program to stop the ... ODM is a proactive, customized program designed to ... drug use while maintaining the necessary balance to ...
(Date:5/22/2013)... , May 22, 2013  MGT Capital Investments, Inc. ... present at the Second Annual Marcum LLP MicroCap Conference ... York City at the Grand Hyatt Hotel.  ... Executive Officer, will update investors and answer questions. ... Company,s presentation is scheduled to begin at 9:30 a.m. ...
(Date:5/22/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB: GNBT) today announced three presentations demonstrating ... developed by its wholly-owned subsidiary, Antigen Express, Inc. ( ... annual meeting of the American Society of Clinical Oncology ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
(Date:5/22/2013)... York, New York (PRWEB) May 22, 2013 ... the nation’s first trial involving a da Vinci lawsuit, ... the case, the family of a man who allegedly died ... seeking more than $8 million in damages from Intuitive Surgical, ... down its physician training program for the da Vinci Surgical ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 ... New York Daily News article titled "Breast ... better sports bras could help." According to ... and found that a substantial amount suffer from breast ... sports bra to correct the issue. , Zensah ...
(Date:5/22/2013)... Pass, OR (PRWEB) May 22, 2013 People ... and it is leading to water shortages. In much of ... luxury, according to water advocate, Sharon Kleyne. She warns against ... conserve the water that is available so easily in the ... Kleyne Hour Power of Water radio show, heard live or ...
(Date:5/22/2013)... May 22, 2013 Diversity Focus and ... This! The performance promotes awareness that physical disabilities ... Handicap This! performance will be held Friday, June 14th ... auditorium. Tickets for Handicap This! can be purchased ... audiences measure the level to which their mind is ...
(Date:5/22/2013)... challenges previous research that suggests umpire discrimination exists ... collaboration between researchers at U-M and the universities ... controversial argument over whether MLB umpires discriminate by ... same race. It found little statistical evidence to ... of sport management at the U-M School of ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... Question. What would happen if,we could clone running with a ... the same. 1. Gyms with their high,membership fees would have ... non-existent. 3. We would never have to spend another dime ... The fitness industry,s take-home pay is now estimated at 35 ...
... Neurological Surgery PC of Long Island, NY, describes ... trained can help relieve some of the symptoms ... a practice composed of some of the most ... Aside from neurological and spine treatments, the practice ...
... Hopkins have determined how the characteristic shedding of fatty ... to evade the body,s immune system, leaving the disease ... one of the most aggressive malignancies, killing more than ... an estimated 15,000 this year. , In a two-year ...
... TODAY AT RED.MSN.COM , , iLIKE CHOSEN ... , PREMIER ISSUE DEBUTS WEDNESDAY, DECEMBER 10 , ... Today, World AIDS Day , many of the greatest artists on the ... innovative new music service from (RED). Throughout the day, visit red.msn.com ...
... and CHICAGO, Dec. 1 Faint magnetic,signals from ... those children,process sound and language differently from non-autistic ... allow researchers to more,accurately diagnose autism and possibly ... disorder. , ...
... of innovations and workflow solutions take center stage at RSNA ... 30 At the 94th Scientific Assembly and Annual ... Chicago, November 30 to December 5, Siemens Healthcare ... its latest diagnostic imaging innovations in computed tomography, mammography, magnetic ...
Cached Medicine News:Health News:Push-Ups: 'It's Horizontal Jogging' 2Health News:Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor 2Health News:Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor 3Health News:Study unmasks how ovarian tumors evade immune system 2Health News:Study unmasks how ovarian tumors evade immune system 3Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 2Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 3Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 4Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 5Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 6Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 7Health News:Brain's Magnetic Fields Reveal Language Delays in Autism 2Health News:Brain's Magnetic Fields Reveal Language Delays in Autism 3Health News:Siemens: Ask the Ultimate Power in Imaging 2Health News:Siemens: Ask the Ultimate Power in Imaging 3Health News:Siemens: Ask the Ultimate Power in Imaging 4Health News:Siemens: Ask the Ultimate Power in Imaging 5Health News:Siemens: Ask the Ultimate Power in Imaging 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: